Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03912194 · ClinicalTrials.gov registry record · Phase 3

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

A Phase 3 study of Tobacco Dependence, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
Phase 3
Development phase
400
Enrollment target
1
Study location

NCT03912194 is a Phase 3 study of Tobacco Dependence that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 400 participants, below the 464-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03912194, a Phase 3 study of Tobacco Dependence, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
Phase 3
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will thus provide essential information regarding a treatment that has the potential to enhance the efficacy of existing smoking cessation interventions, thereby having a beneficial impact on the public health of the United States.

Conditions Studied

Tobacco Dependence

Interventions

  • BEHAVIORAL cognitive-behavioral withdrawal regulation strategies
  • BEHAVIORAL relaxation strategies
  • BEHAVIORAL early withdrawal exposure

Study Locations (1)

Alabama

  • Ryals Public Health Building - Birmingham

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2019-08-01
Est. Completion 2026-07-01
Phase Phase 3

Sponsor

University of Alabama at Birmingham

1,160 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03912194

The ClinicalTrials.gov registry entry for NCT03912194 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 464-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (14% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 3 interventions - of which cognitive-behavioral withdrawal regulation strategies is the first listed.

NCT03912194 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03912194 about?

NCT03912194 is a clinical study titled "Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation". Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will...

What is the current status of trial NCT03912194?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2019-08-01. Estimated completion is 2026-07-01.

What conditions does trial NCT03912194 study?

This clinical trial studies the following conditions: Tobacco Dependence.

What interventions are being tested in trial NCT03912194?

The interventions under investigation include: cognitive-behavioral withdrawal regulation strategies (BEHAVIORAL), relaxation strategies (BEHAVIORAL), early withdrawal exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT03912194?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03912194 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Dependence

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.